Statistical Considerations in the Design of Clinical Trials Targeting Prodromal Parkinson Disease. Macklin EA, Coffey CS, Brumm MC, Seibyl JP, et al. Neurology 2022;99.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Macklin EA, Coffey CS, Brumm MC, Seibyl JP, et al. Statistical Considerations in the Design of Clinical Trials Targeting Prodromal Parkinson Disease. Neurology 2022;99.
PMID: 35970588